Condition
Spinal Tumors
Total Trials
6
Recruiting
3
Active
3
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (4)
P 1 (1)
Trial Status
Recruiting3
Completed3
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07429422Not ApplicableRecruiting
SBRT Technique Implementation for Spinal Metastases Irradiation
NCT07224451Not ApplicableRecruitingPrimary
Liquid Biopsy Following BBB Disruption Using Barrier Disrupting Fields in Patients Undergoing Spine Surgery
NCT06869746RecruitingPrimary
Swiss Spinal Tumor Registry (Swiss-STR)
NCT02013297Not ApplicableCompleted
Study of SBRT Efficacy on Intra and Extra -Cranial Tumors or Metastasis in Pediatrics Population (SBRT Pediatrics)
NCT01637766Phase 1Completed
Intra-arterial Chemotherapy for Spinal Metastases
NCT00631670Not ApplicableCompletedPrimary
Stereotactic Body Radiation Therapy (SBRT) for Tumors Near the Spinal Cord
Showing all 6 trials